These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17803610)

  • 21. Topical hydroquinone in the treatment of some hyperpigmentary disorders.
    Amer M; Metwalli M
    Int J Dermatol; 1998 Jun; 37(6):449-50. PubMed ID: 9646135
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of exogenous ochronosis with a Q-switched alexandrite (755 nm) laser.
    Bellew SG; Alster TS
    Dermatol Surg; 2004 Apr; 30(4 Pt 1):555-8. PubMed ID: 15056151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Toxicological aspects and health risks associated with hydroquinone in skin bleaching formula].
    Kooyers TJ; Westerhof W
    Ned Tijdschr Geneeskd; 2004 Apr; 148(16):768-71. PubMed ID: 15129564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The safety of hydroquinone.
    Nordlund JJ; Grimes PE; Ortonne JP
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):781-7. PubMed ID: 16898897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroquinone-induced exogenous ochronosis in Chinese--two case reports and a review.
    Tan SK; Sim CS; Goh CL
    Int J Dermatol; 2008 Jun; 47(6):639-40. PubMed ID: 18477169
    [No Abstract]   [Full Text] [Related]  

  • 26. Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized study.
    Lowe N; Horwitz S; Tanghetti E; Draelos Z; Menter A
    J Cosmet Laser Ther; 2006 Sep; 8(3):121-7. PubMed ID: 16971360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone.
    Kakita LS; Lowe NJ
    Clin Ther; 1998; 20(5):960-70. PubMed ID: 9829447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exogenous ochronosis--a diagnostic challenge.
    Tan SK
    J Cosmet Dermatol; 2010 Dec; 9(4):313-7. PubMed ID: 21122051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melasma. Etiologic and therapeutic considerations.
    Grimes PE
    Arch Dermatol; 1995 Dec; 131(12):1453-7. PubMed ID: 7492140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical agents used in the management of hyperpigmentation.
    Halder RM; Richards GM
    Skin Therapy Lett; 2004; 9(6):1-3. PubMed ID: 15334278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exogenous ochronosis in a Mexican-American woman.
    Howard KL; Furner BB
    Cutis; 1990 Mar; 45(3):180-2. PubMed ID: 2311433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin lightening preparations and the hydroquinone controversy.
    Draelos ZD
    Dermatol Ther; 2007; 20(5):308-13. PubMed ID: 18045355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperpigmentation: Looking beyond hydroquinone.
    Charoo NA
    J Cosmet Dermatol; 2022 Oct; 21(10):4133-4145. PubMed ID: 35020267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skin bleaching: highlighting the misuse of cutaneous depigmenting agents.
    Dadzie OE; Petit A
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):741-50. PubMed ID: 19470077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Randomized, Investigator-Blinded Comparison of Two Topical Regimens in Fitzpatrick Skin Types III-VI With Moderate to Severe Facial Hyperpigmentation.
    Vanaman Wilson MJ; Jones IT; Bolton J; Larsen L; Wu DC; Goldman MP
    J Drugs Dermatol; 2017 Nov; 16(11):1127-1132. PubMed ID: 29141061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exogenous ochronosis from hydroquinone bleaching cream.
    Fisher AA
    Cutis; 1998 Jul; 62(1):11-2. PubMed ID: 9675524
    [No Abstract]   [Full Text] [Related]  

  • 37. Cosmetic ochronosis caused by bleaching creams containing 2% hydroquinone.
    Weiss RM; del Fabbro E; Kolisang P
    S Afr Med J; 1990 Apr; 77(7):373. PubMed ID: 2321111
    [No Abstract]   [Full Text] [Related]  

  • 38. Diagnostic utility of dermatoscopy in hydroquinone-induced exogenous ochronosis.
    Mishra SN; Dhurat RS; Deshpande DJ; Nayak CS
    Int J Dermatol; 2013 Apr; 52(4):413-7. PubMed ID: 22348652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localized exogenous ochronosis.
    Cullison D; Abele DC; O'Quinn JL
    J Am Acad Dermatol; 1983 Jun; 8(6):882-9. PubMed ID: 6863651
    [No Abstract]   [Full Text] [Related]  

  • 40. Exogenous ochronosis: a comprehensive review of the diagnosis, epidemiology, causes, and treatments.
    Simmons BJ; Griffith RD; Bray FN; Falto-Aizpurua LA; Nouri K
    Am J Clin Dermatol; 2015 Jun; 16(3):205-12. PubMed ID: 25837718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.